Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Meijer

Showing results (541-550 of 1,090) with videos related to

Pageof 109
Sort By:
The American Journal of Pathology|June 12, 2002
Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesisRenske D M Steenbergen, Vanessa E OudeEngberink, Debbie Kramer, et al.
International Journal of Cancer|October 26, 2007
Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancerJillian de Wilde, Saskia M Wilting, Chris J L M Meijer, et al.
The American Journal of Pathology|January 27, 2004
Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomasFrank M Raaphorst, Maarten Vermeer, Elly Fieret, et al.
Journal of the American Academy of Dermatology|November 21, 2017
Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseasesJoost M Meijer, Ingeborg Atefi, Gilles F H Diercks, et al.
Journal of Clinical Pathology|August 7, 2007
High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3S Bulk, L Rozendaal, G D Zielinski, et al.
Expert Review of Molecular Diagnostics|July 27, 2016
Management of high-risk HPV-positive women for detection of cervical (pre)cancerRoosmarijn Luttmer, Lise M A De Strooper, Renske D M Steenbergen, et al.
Clinical Immunology (Orlando, Fla.)|January 11, 2005
Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancerKirsten B J Scholten, Marco W J Schreurs, Janneke J Ruizendaal, et al.
British Journal of Cancer|January 13, 2006
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The NetherlandsS Bulk, J Berkhof, N W J Bulkmans, et al.
The Journal of Pathology|August 8, 2009
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesisRenée M Overmeer, Florianne E Henken, Mariska Bierkens, et al.
Inorganic Chemistry|December 8, 2011
Synthesis, characterization, and DNA binding properties of ruthenium(II) complexes containing the redox active ligand benzo[i]dipyrido[3,2-a:2',3'-c]phenazine-11,16-quinoneSimon P Foxon, Charlotte Green, Michael G Walker, et al.
Pageof 109

Showing results (541-550 of 1,090) with videos related to

Sort By:
Pageof 109
The American Journal of Pathology|June 12, 2002
Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesisRenske D M Steenbergen, Vanessa E OudeEngberink, Debbie Kramer, et al.
International Journal of Cancer|October 26, 2007
Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancerJillian de Wilde, Saskia M Wilting, Chris J L M Meijer, et al.
The American Journal of Pathology|January 27, 2004
Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomasFrank M Raaphorst, Maarten Vermeer, Elly Fieret, et al.
Journal of the American Academy of Dermatology|November 21, 2017
Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseasesJoost M Meijer, Ingeborg Atefi, Gilles F H Diercks, et al.
Journal of Clinical Pathology|August 7, 2007
High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3S Bulk, L Rozendaal, G D Zielinski, et al.
Expert Review of Molecular Diagnostics|July 27, 2016
Management of high-risk HPV-positive women for detection of cervical (pre)cancerRoosmarijn Luttmer, Lise M A De Strooper, Renske D M Steenbergen, et al.
Clinical Immunology (Orlando, Fla.)|January 11, 2005
Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancerKirsten B J Scholten, Marco W J Schreurs, Janneke J Ruizendaal, et al.
British Journal of Cancer|January 13, 2006
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The NetherlandsS Bulk, J Berkhof, N W J Bulkmans, et al.
The Journal of Pathology|August 8, 2009
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesisRenée M Overmeer, Florianne E Henken, Mariska Bierkens, et al.
Inorganic Chemistry|December 8, 2011
Synthesis, characterization, and DNA binding properties of ruthenium(II) complexes containing the redox active ligand benzo[i]dipyrido[3,2-a:2',3'-c]phenazine-11,16-quinoneSimon P Foxon, Charlotte Green, Michael G Walker, et al.
Pageof 109